2-{3-[2-(4-Bromo-benzyloxy)-phenyl]-isoxazol-5-yl}-ethanol

ID: ALA85369

PubChem CID: 10474526

Max Phase: Preclinical

Molecular Formula: C18H16BrNO3

Molecular Weight: 374.23

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  OCCc1cc(-c2ccccc2OCc2ccc(Br)cc2)no1

Standard InChI:  InChI=1S/C18H16BrNO3/c19-14-7-5-13(6-8-14)12-22-18-4-2-1-3-16(18)17-11-15(9-10-21)23-20-17/h1-8,11,21H,9-10,12H2

Standard InChI Key:  KSRJHOZSWOAYJW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
    1.8542    1.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9792    2.4458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6042    1.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1417    1.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7917    2.5833    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750    1.8583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1417    0.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8542   -0.0292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0000    1.7583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8542   -0.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -2.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1375   -1.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0125   -2.5292    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.4250   -2.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2958   -1.2792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1375   -2.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4250   -0.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4250    1.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1417    0.9083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3292    1.0083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4292   -0.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2875    1.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2875    0.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  1  1  0
  5  2  1  0
  6  3  2  0
  7  4  1  0
  8  7  1  0
  9  6  1  0
 10  8  1  0
 11 15  2  0
 12 10  1  0
 13 11  1  0
 14 16  2  0
 15 17  1  0
 16 12  1  0
 17 12  2  0
 18  4  2  0
 19 20  1  0
 20  9  1  0
 21  7  2  0
 22 18  1  0
 23 22  2  0
  5  6  1  0
 21 23  1  0
 11 14  1  0
M  END

Associated Targets(non-human)

Cftr Cystic fibrosis transmembrane conductance regulator (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 374.23Molecular Weight (Monoisotopic): 373.0314AlogP: 4.22#Rotatable Bonds: 6
Polar Surface Area: 55.49Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.08CX LogP: 3.92CX LogD: 3.92
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.70Np Likeness Score: -0.96

References

1. Sammelson RE, Ma T, Galietta LJ, Verkman AS, Kurth MJ..  (2003)  3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators.,  13  (15): [PMID:12852954] [10.1016/s0960-894x(03)00482-7]

Source